Prediction of PFS and OS under third and fourth line chemotherapy among metastatic triple-negative breast cancer patients in the national multicenter ESME metastatic breast cancer cohort

Affiliation auteurs!!!! Error affiliation !!!!
TitrePrediction of PFS and OS under third and fourth line chemotherapy among metastatic triple-negative breast cancer patients in the national multicenter ESME metastatic breast cancer cohort
Type de publicationJournal Article
Year of Publication2020
AuteursCabel L, Carton M, Pistilli B, Dalenc F, Vanlemnens L, Levy C, Jacot W, Debled M, Loeb A, Coudert B, Rouge TDe la Mott, Laborde L, Laurent C, Chamorey E, Parent D, Petit T, Mouret-Reynier M-A, Perrocheau G, Labreveux C, Bachelot T, Robain M, Lerebours F
JournalCANCER RESEARCH
Volume80
Date PublishedFEB
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.SABCS19-P5-06-18